Tal Danino

Health Sciences and Technology, Massachusetts Institute of Technology

Affiliated withMassachusetts Institute of Technology Columbia University Columbia College

Research Area

Biography

Tal Danino has not added Biography.
If you are Tal Danino and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 22	2013
Publication title	2024

Other Publications

Article	Year
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science (New York, N.Y.)\| PubMed ID: 28912244	2017
Spatial Control of Bacteria Using Screen Printing. 3D printing and additive manufacturing\| PubMed ID: 29577061	2016
Advances in bacterial cancer therapies using synthetic biology. Current opinion in systems biology\| PubMed ID: 29881788	2017
Synthetic Biology and Engineered Live Biotherapeutics: Toward Increasing System Complexity. Cell systems\| PubMed ID: 30048620	2018
Two New Plasmid Post-segregational Killing Mechanisms for the Implementation of Synthetic Gene Networks in Escherichia coli. iScience\| PubMed ID: 30954530	2019
Rapid screening of engineered microbial therapies in a 3D multicellular model. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 30996123	2019
Programmable bacteria induce durable tumor regression and systemic antitumor immunity. Nature medicine\| PubMed ID: 31270504	2019
Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies. Science translational medicine\| PubMed ID: 32051224	2020
Engineered Probiotics for Detection and Treatment of Inflammatory Intestinal Diseases. Frontiers in bioengineering and biotechnology\| PubMed ID: 32296696	2020
Engineered Bacterial Production of Volatile Methyl Salicylate. ACS synthetic biology\| PubMed ID: 33331760	2021
Quantitative measurements of early alphaviral replication dynamics in single cells reveals the basis for superinfection exclusion. Cell systems\| PubMed ID: 33515490	2021
Engineering bacteria for cancer therapy. Emerging topics in life sciences\| PubMed ID: 33523173	2019
Enhancing the tropism of bacteria via genetically programmed biosensors. Nature biomedical engineering\| PubMed ID: 34326488	2022
The Origin and Contribution of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis. Gastroenterology\| PubMed ID: 34883119	2022
CAR-T cells SEAK help from enzymes. Nature chemical biology\| PubMed ID: 34969971	2022
Bacterial couriers as cancer vaccines. Nature biomedical engineering\| PubMed ID: 35058588	2022
Reimagining cancer research with art. Nature reviews. Cancer\| PubMed ID: 35140359	2022
A programmable encapsulation system improves delivery of therapeutic bacteria in mice. Nature biotechnology\| PubMed ID: 35301496	2022
A rapid screening platform to coculture bacteria within tumor spheroids. Nature protocols\| PubMed ID: 35906291	2022
Engineering bacteria as interactive cancer therapies. Science (New York, N.Y.)\| PubMed ID: 36423303	2022
Assessing chemotherapy dosing strategies in a spatial cell culture model. Frontiers in oncology\| PubMed ID: 36505801	2022
Design of combination therapy for engineered bacterial therapeutics in non-small cell lung cancer. Scientific reports\| PubMed ID: 36513723	2022
Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity. Science advances\| PubMed ID: 36888717	2023
Engineered Bacteria for Short-Chain-Fatty-Acid-Repressed Expression of Biotherapeutic Molecules. Microbiology spectrum\| PubMed ID: 36939337	2023
Engineered bacterial swarm patterns as spatial records of environmental inputs. Nature chemical biology\| PubMed ID: 37142806	2023
Probiotic-guided CAR-T cells for solid tumor targeting. Science (New York, N.Y.)\| PubMed ID: 37824640	2023
Engineering Probiotic E. coli Nissle 1917 for Release of Therapeutic Nanobodies. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 38070121	2024
Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia. Nature communications\| PubMed ID: 38245513	2024